121 related articles for article (PubMed ID: 8646002)
1. [-Effect of endogenous opioids on adrenal cortex activity in women with hypothalamic amenorrhea-].
Krause BT; Möller S
Gynakol Geburtshilfliche Rundsch; 1995; 35(4):194-8. PubMed ID: 8646002
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity.
Nappi RE; Petraglia F; Genazzani AD; D'Ambrogio G; Zara C; Genazzani AR
Fertil Steril; 1993 Mar; 59(3):571-6. PubMed ID: 8384575
[TBL] [Abstract][Full Text] [Related]
3. [The influence of endogenous opioids in hypothalamic amenorrhea. Diagnostic and therapeutic aspects].
Krause B; Möller S; Ulrich U; Göretzlehner G
Zentralbl Gynakol; 1989; 111(20):1368-73. PubMed ID: 2555982
[TBL] [Abstract][Full Text] [Related]
4. Naloxone stimulation test in women with hypothalamic amenorrhea: a preliminary report.
Krause B; Møller S; Göretzlehner G; Ulrich U; Matuszewski F; Wodrig W; Weber A
Exp Clin Endocrinol; 1992; 99(2):113-5. PubMed ID: 1322310
[TBL] [Abstract][Full Text] [Related]
5. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
[TBL] [Abstract][Full Text] [Related]
6. [Possibility of ovulation induction using naloxone in women with hypothalamic amenorrhea].
Krause B; Möller S; Göretzlehner G
Zentralbl Gynakol; 1991; 113(22):1221-33. PubMed ID: 1661461
[TBL] [Abstract][Full Text] [Related]
7. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
Facchinetti F; Fioroni L; Martignoni E; Sances G; Costa A; Genazzani AR
Psychosom Med; 1994; 56(5):418-22. PubMed ID: 7809341
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of disturbances of the hypothalamic-pituitary-adrenal axis in women with progestin-negative functional hypothalamic amenorrhea.
Kondoh Y; Uemura T; Murase M; Yokoi N; Ishikawa M; Hirahara F
Fertil Steril; 2001 Oct; 76(4):748-52. PubMed ID: 11591409
[TBL] [Abstract][Full Text] [Related]
10. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
Boushaki FZ; Rasio E; Serri O
Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
Nye EJ; Bornstein SR; Grice JE; Tauchnitz R; Hockings GI; Strakosch CR; Jackson RV; Torpy DJ
J Neuroendocrinol; 2000 Feb; 12(2):141-5. PubMed ID: 10718909
[TBL] [Abstract][Full Text] [Related]
14. [The hypothalamus-hypophysis-adrenal system in patients with lactorrhea-amenorrhea syndrome].
Oleĭnik VA; Luchitskiĭ EV; Valueva GV
Probl Endokrinol (Mosk); 1989; 35(5):14-8. PubMed ID: 2555814
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
Scott LV; Burnett F; Medbak S; Dinan TG
Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
[TBL] [Abstract][Full Text] [Related]
16. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
Guido M; Ciampelli M; Fulghesu AM; Pavone V; Barini A; de Marinis L; Cento R; Caruso A; Lanzone A
Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
[TBL] [Abstract][Full Text] [Related]
17. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
[TBL] [Abstract][Full Text] [Related]
18. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ; Prickett TC; Mulder RT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[TBL] [Abstract][Full Text] [Related]
19. Hypercortisolism in patients with functional hypothalamic-amenorrhea.
Suh BY; Liu JH; Berga SL; Quigley ME; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1988 Apr; 66(4):733-9. PubMed ID: 3346352
[TBL] [Abstract][Full Text] [Related]
20. Endocrine actions of opioids.
Pfeiffer A; Herz A
Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
